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CBC

:   complete blood cell count

1. CASE 1 {#jvim15312-sec-0001}
=========

An 8‐month‐old male intact mixed‐breed dog was referred to the Neurology Service of the University of Glasgow for investigation of a 1‐month history of chronic progressive gait abnormalities. The owners had noticed that the dog was chewing its paw for 3--4 months before referral and then developed gradually deteriorating ataxia and knuckling over in the pelvic limbs during the month before evaluation. At that stage, urinary incontinence also was observed, with the dog passing urine intermittently, even when walking. CBC and serum biochemistry were unremarkable. Radiographs of the thoracolumbar vertebral column were obtained and no abnormalities were detected. No information was available regarding ancestors or other littermates, but the circumstances suggested that the puppy was from a farm.

Physical examination findings included multiple wounds on the distal aspect of all 4 limbs. Neurological examination identified normal mentation and cranial nerve function. Gait assessment disclosed severe proprioceptive ataxia in all limbs with the pelvic limbs more severely affected including occasional knuckling of the hind paws. Paw positioning and hopping were decreased to absent in all limbs. Withdrawal reflex was absent in all limbs, but patellar, perineal, and cutaneous trunci reflexes were intact. Superficial and deep pain perception was absent distally in all limbs but present proximally, and in the tail, trunk, and head. Findings were consistent with a peripheral sensory neuropathy with partial autonomic involvement as suggested by the urinary incontinence.

Repeated CBC and serum biochemistry profile did not identify any abnormalities. Serology testing for *Toxoplasma gondii* and *Neospora caninum* was negative. Electromyography disclosed mild spontaneous electrical activity in multiple distal appendicular muscles in all limbs. Motor nerve conduction velocity of the ulnar, sciatic, and common fibular nerves was within normal range. Muscle cryosections from the biceps femoris and gastrocnemius muscles were evaluated using a standard panel of histochemical stains and reactions. No specific abnormalities were identified in either muscle. A formalin‐fixed biopsy from the common fibular nerve was embedded in resin and evaluated using 1 μm sections (Figure [1](#jvim15312-fig-0001){ref-type="fig"}). Multifocal areas of nerve fiber loss were present without obvious axonal degeneration or demyelination. It could not be determined if areas of nerve fiber loss involved mainly sensory or motor fibers in this mixed nerve. To our knowledge, a method of distinguishing motor from sensory fibers histologically in a mixed nerve is not available. A sensory nerve would have provided clarification but was not submitted for evaluation. A presumptive diagnosis of sensory neuropathy was established.

![Resin‐embedded thick sections (1 μm) of a common fibular nerve fascicle stained with toluidine blue‐acid fuchsin. Numerous collagenous bundles consistent with resolving subperineurial edema are present in the subperineurium. Arrows depict representative areas of nerve fiber loss. The distribution of sensory and motor nerve fibers in this mixed nerve could not be determined](JVIM-32-2082-g001){#jvim15312-fig-0001}

To decrease the frequency and severity of mutilations, treatment with pregabalin (Pregabalin Teva 25 mg capsules, TEVA UK Limited, Eastbourne, United Kingdom) was initiated (2 mg/kg PO q8h). Unfortunately, clinical signs continued to progress despite treatment, and the owner requested a second opinion from the neurology service of Fitzpatrick Referrals. Repeated neurological examination suggested progression of signs. The urinary incontinence was more pronounced and compatible with an autonomic bladder, with frequent pollakiuria, and fecal incontinence was present. The dog was indifferent to distal painful stimuli and had absent withdrawal reflexes in all 4 limbs. However, a behavioral response was observed to a painful stimulus when applied proximally on the thoracic limbs, with a very slight withdrawal reflex. Nociception was still present in the tail. Cutaneous trunci reflex was absent caudal to the level of the T10 vertebra. The perineal reflex, despite fecal incontinence, was intact. Patellar reflexes were absent. Cranial nerve function including facial sensation was intact. The dog failed to correct a knuckled over paw, in the thoracic limbs as well as in the pelvic limbs. The dog did, however, place the thoracic limbs normally and had normal hopping ability. Hopping ability was absent in the pelvic limbs. In addition, the dog recurrently chewed on its limbs. Unfortunately, clinical signs continued to progress and the owners elected euthanasia 4 months after the first neurological consultation.

Because of clinical and histopathological similarities with previously reported Border Collie sensory neuropathy[1](#jvim15312-bib-0001){ref-type="ref"} and despite the fact that the dog did not resemble a Border Collie (Figure [2](#jvim15312-fig-0002){ref-type="fig"}), it was decided to screen for the recently reported mutation in the *FAM134B* gene and the dog was found to be homozygous.

![Diagram showing the ancestors of Case 1: 37.5% corresponded to Border Collie, 25% to Bichon Frise, and the rest (37.5%) to mixed breed groups](JVIM-32-2082-g002){#jvim15312-fig-0002}

2. CASE 2 {#jvim15312-sec-0002}
=========

An 8‐month‐old male intact mixed‐breed dog of unknown ancestry was presented to the Neurology Service of Northwest Veterinary Specialists for evaluation of gait abnormalities similar to those of Case 1. The owners initially observed the clinical signs when the dog was approximately 6.5 months of age. Pelvic limb ataxia and occasional spontaneous knuckling were observed. Trial treatment with meloxicam (Metacam 1.5 mg/mL oral solution, Boehringer Ingelheim, United Kingdom; 0.2 mg/kg PO q24h for 7 days) followed by a combination of prednisolone (Prednisolone tablets B.P. \[Vet\], Millpledge Veterinary, United Kingdom; 1 mg/kg PO q12h for 5 days followed by 1 mg/kg PO q48h) and clindamycin (Clinacin tablets, Chanelle, United Kingdom; 7.5 mg/kg PO q12h for 5 days) was not effective, clinical signs progressively worsened, and the medications were discontinued. On referral, the patient had severe gait disturbance and was almost consistently standing on the dorsal aspects of its pelvic digits. The owner also described the occurrence of defecation during walking.

Physical examination disclosed multiple wounds in the distal aspect of all 4 limbs. Neurological examination identified normal mentation and cranial nerve function. Gait assessment disclosed severe proprioceptive ataxia in all limbs. The pelvic limbs were more severely affected, with bilateral hyperextended tarso‐crural joints and standing on the dorsal aspect of the pelvic digits. Severe valgus deformity of both carpi was present. Paw positioning and hopping were absent in the pelvic limbs and decreased in the thoracic limbs. The withdrawal reflex was absent in all limbs, but patellar and perineal reflexes were intact. Deep and superficial pain perception was absent distally in all limbs and in the tail, but present proximally and in the trunk and head. The findings were consistent with a peripheral sensory neuropathy with partial autonomic involvement, as suggested by fecal incontinence.

A CBC and serum biochemistry profile did not identify any abnormalities, except for a mild increase in creatine kinase activity of 465 U/L (normal ≤190 U/L). Serology testing for *T. gondii* and *N. caninum* was negative. Again, because of the clinical similarities with previously reported Border Collie sensory neuropathy,[1](#jvim15312-bib-0001){ref-type="ref"} the dog was screened for the recently reported mutation in the *FAM134B* gene and found to be homozygous. Phenotypically, the dog did not resemble a Border Collie (Figure [3](#jvim15312-fig-0003){ref-type="fig"}). The dog was lost to follow‐up, and the post‐mortem examination was declined by the owner.

![Diagram showing the ancestors of the Case 2: 25% corresponded to Border Collie, 37.5% mixed breed groups, 25% Parson Russell Terrier, and 12.5% Labrador Retriever](JVIM-32-2082-g003){#jvim15312-fig-0003}

Herein we describe 2 cases of sensory neuropathy caused by an inversion disrupting *FAM134B* in a dog other than a pure‐breed Border Collie. Sensory neuropathy in the Border Collie is an autosomal recessive disease characterized by chronic and progressive proprioceptive ataxia, proprioceptive deficits, loss of nociception, self‐mutilation, and in some cases, autonomic signs such as urinary incontinence.[1](#jvim15312-bib-0001){ref-type="ref"}, [2](#jvim15312-bib-0002){ref-type="ref"}, [3](#jvim15312-bib-0003){ref-type="ref"}, [4](#jvim15312-bib-0004){ref-type="ref"} Recently, a genetic mutation was found affecting the *FAM134B* gene in Border Collies with clinical signs compatible with sensory neuropathy.[1](#jvim15312-bib-0001){ref-type="ref"} The *FAM134B* gene encodes a cis‐Golgi protein found in sensory and autonomic neurons. Although not completely understood, this defect induces apoptosis in neurons of the dorsal root ganglia.[1](#jvim15312-bib-0001){ref-type="ref"}

Sensory neuropathies with or without autonomic involvement have been reported in other canine breeds, such as long‐haired Dachshund,[5](#jvim15312-bib-0005){ref-type="ref"}, [6](#jvim15312-bib-0006){ref-type="ref"} Miniature Pinscher,[7](#jvim15312-bib-0007){ref-type="ref"} and Jack Russell Terrier[8](#jvim15312-bib-0008){ref-type="ref"} in which the responsible genetic mutation has not yet been identified, and in the Pointer,[9](#jvim15312-bib-0009){ref-type="ref"}, [10](#jvim15312-bib-0010){ref-type="ref"}, [11](#jvim15312-bib-0011){ref-type="ref"}, [12](#jvim15312-bib-0012){ref-type="ref"} English Springer Spaniel, and French Spaniel[13](#jvim15312-bib-0013){ref-type="ref"} breeds in which a mutation in the *GDNF* gene recently has been identified (Table [1](#jvim15312-tbl-0001){ref-type="table"}).[14](#jvim15312-bib-0014){ref-type="ref"} A neurodegenerative disease affecting central and peripheral sensory and motor axons has been reported in Golden Retriever dogs and is caused by a deletion in the mitochondrial tRNA^Tyr^ gene.[15](#jvim15312-bib-0015){ref-type="ref"}, [16](#jvim15312-bib-0016){ref-type="ref"}

###### 

Hereditary sensory neuropathies previously described in dogs

  Breed                            Border Collie[1](#jvim15312-bib-0001){ref-type="ref"}, [2](#jvim15312-bib-0002){ref-type="ref"}, [3](#jvim15312-bib-0003){ref-type="ref"}, [4](#jvim15312-bib-0004){ref-type="ref"}   Jack Russell Terrier[8](#jvim15312-bib-0008){ref-type="ref"}   Long‐haired Dachshund[5](#jvim15312-bib-0005){ref-type="ref"}, [6](#jvim15312-bib-0006){ref-type="ref"}                                           Pointer dogs[11](#jvim15312-bib-0011){ref-type="ref"}                                                                                                                                                French Spaniel[13](#jvim15312-bib-0013){ref-type="ref"}   Miniature Pinscher[7](#jvim15312-bib-0007){ref-type="ref"}
  -------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age of presentation              2‐7 months                                                                                                                                                                            6 years^a^                                                     8‐12 weeks                                                                                                                                        2‐12 months                                                                                                                                                                                          3.5‐12 months                                             6 months[a](#jvim15312-note-0001){ref-type="fn"}
  Clinical signs                   Proprioceptive ataxiaKnucklingHyperextension of limbsDecreased or loss of proprioception and nociceptionAutonomic signs such as urinary/fecal incontinenceSelf‐mutilation             Hypermetric gaitProprioceptive deficitsLoss of nociception     Proprioceptive ataxiaDecreased or loss of proprioception and nociceptionAutonomic signs such as vomiting or urinary incontinenceSelf‐mutilation   Decreased pain perception proximal to the carpus and tarsus.Loss of pain perception to the distal aspect of the paw.Self‐mutilation                                                                  Similar to Pointer dogs                                   Decreased pain perception in the distal pelvic limbsHyperesthesia on palpation of the lumbar regionSelf‐mutilation
  Diagnosis                        Decreased or absent sensory nerve compound action potentialsDecreased or normal motor nerve conduction velocities                                                                     Unknown                                                        Decreased of absent sensory nerve compound action potentialsNormal electromyography                                                               Normal electrodiagnostics                                                                                                                                                                            Normal electrodiagnostics                                 Unknown
  Treatment                        Unknown                                                                                                                                                                               Unknown                                                        Unknown                                                                                                                                           Unknown                                                                                                                                                                                              Unknown                                                   Unknown
  Histopathology                   Axonal degenerationEndoneurial fibrosisExtensive large nerve fiber loss                                                                                                               Endoneurial and epineurial fibrosis                            Decreased number of myelinated fibersDegeneration of unmyelinated axons, most predominant distally.                                               Decreased number of ganglionic cell bodies without remarkable neuronal degenerationReduced fiber density and myelin staining in the spinal cordLack of staining for substance P in the spinal cord   No abnormalities were detected                            Reduced number of neurons in the lumbosacral spinal gangliaLoss of nerve fibers and endoneurial proliferation with Wallerian degeneration in the dorsal nerve roots
  Genetic mutation identified in   *FAM134B*                                                                                                                                                                             Unknown                                                        Unknown                                                                                                                                           *GDNF*                                                                                                                                                                                               *GDNF*                                                    Unknown

The age of presentation in Jack Russell Terrier and Miniature Pinscher remains unclear as this disease has been reported in one single case in both breeds.[7](#jvim15312-bib-0007){ref-type="ref"}, [8](#jvim15312-bib-0008){ref-type="ref"} In the Jack Russell, although the clinical signs worsened when the dog was 6 years old, progressive abnormal pelvic limb posture was noticed since birth. In the Miniature Pinscher, the dog presented at 18 months of age, although the clinical signs were first noticed 12 months prior.

Hereditary sensory and autonomic neuropathies (HSAN) are well described in humans and represent a group of seven (I‐VII) disorders characterized by progressive sensory loss and ulcerative mutilation in combination with variable autonomic and motor disturbances associated with sensory and autonomic dysfunction.[17](#jvim15312-bib-0017){ref-type="ref"}, [18](#jvim15312-bib-0018){ref-type="ref"} Molecular genetics studies have identified disease‐causing mutations in 12 genes. Some of the affected proteins have nerve‐specific roles, for example, nerve growth factor and receptor. Underlying mechanisms also have been shown to involve sphingolipid metabolism, vesicular transport, structural integrity, and transcription regulation.[19](#jvim15312-bib-0019){ref-type="ref"} Interestingly, although most of these disorders are autosomal recessive (II‐VI), HSAN Types I and VII are dominant disorders. Type I HSAN is caused by a mutation in the *SPTLC1* gene. This gene encodes a serine palmitoyltransferase responsible for the synthesis of sphingolipids, ceramide, and sphingomyelin.[20](#jvim15312-bib-0020){ref-type="ref"} Similar to the sensory neuropathy in the Border Collie, *FAM134B* gene mutations have been found to cause HSAN II[21](#jvim15312-bib-0021){ref-type="ref"} and play a role in the etiology of some types of neoplasia such as esophageal squamous cell carcinoma and colorectal cancer in people.[22](#jvim15312-bib-0022){ref-type="ref"}, [23](#jvim15312-bib-0023){ref-type="ref"} A previous study in mice showed high expression of this gene in the dorsal root ganglia and reported that nociceptive neurons seem to be especially sensitive to deletion of FAM134B, therefore causing the characteristic clinical signs of HSAN II.[21](#jvim15312-bib-0021){ref-type="ref"} Separately, from HSAN, Charcot‐Marie‐Tooth (CMT) disease, is one of the most common motor and sensory inherited neuropathies in humans.[24](#jvim15312-bib-0024){ref-type="ref"} Affected people can present with a primary axonopathy or an axonopathy secondary to a myelination defect in Schwann cells.[25](#jvim15312-bib-0025){ref-type="ref"} Multiple studies have been performed and several genetic defects have been encountered. For example, approximately 75% of cases of the demyelinating form (CMT1) are caused by duplication in the short arm region of chromosome 17 in combination with mutations in *PMP22*, *MPZ*, or *GJB*.[24](#jvim15312-bib-0024){ref-type="ref"} Nevertheless, classification of HSAN and CMT still is incomplete, and some clinical and genetic overlap may exist.

Intriguingly, mutation of *FAM134B* was responsible for the development of disease in these unrelated mixed breed dogs, despite the fact that they phenotypically looked more like a Jack Russell and a Parson Russell than a Border Collie, respectively (Figures [2](#jvim15312-fig-0002){ref-type="fig"} and [3](#jvim15312-fig-0003){ref-type="fig"}). Because we were interested in knowing if the mutation was more widespread in the canine population than previously thought, or if there was any Border Collie ancestry in these dogs, a DNA sample was submitted for a commercially available canine breed ancestry test (Wisdom Panel, Mars Veterinary, Vancouver, WA, USA). The results suggested Border Collie ancestry in both dogs (Figures [2](#jvim15312-fig-0002){ref-type="fig"} and [3](#jvim15312-fig-0003){ref-type="fig"}). However, these results should be interpreted with caution, because to our knowledge no scientific publications validate the sensitivity or specificity of the algorithm currently used for this test. Although, most likely the mutation arose from Border Collie ancestry, it is impossible to determine this possibility with certainty. The presence of a specific mutation causing the same neurodegenerative condition in \> 1 breed has been described previously in veterinary medicine. For example, until recently, all mutations causing neuronal ceroid lipofuscinosis in dogs were reported to occur in members of a single breed, but 2 recent studies have reported a previously identified mutation in a second breed.[24](#jvim15312-bib-0024){ref-type="ref"}, [25](#jvim15312-bib-0025){ref-type="ref"} The fact that these gene alterations have been encountered in multiple breeds suggests that these diseases may be a consequence of more ancient mutations widely spread throughout the canine population.[26](#jvim15312-bib-0026){ref-type="ref"}

Also as previously reported, hereditary genetic diseases can affect mixed‐breed dogs and characterizing them also may help other breeds.[26](#jvim15312-bib-0026){ref-type="ref"}, [27](#jvim15312-bib-0027){ref-type="ref"}, [28](#jvim15312-bib-0028){ref-type="ref"}, [29](#jvim15312-bib-0029){ref-type="ref"}, [30](#jvim15312-bib-0030){ref-type="ref"} In 2 recently published studies, it was found that a large number of mixed‐breed dogs carried autosomal recessive mutations.[29](#jvim15312-bib-0029){ref-type="ref"}, [30](#jvim15312-bib-0030){ref-type="ref"} In these studies, the same commercially available canine breed ancestry test (Wisdom Panel, Mars Veterinary) was used, and it was found that many of the mixed‐breed dogs carrying the alternate or mutant allele had the specific breed, in which the mutation initially was identified, in their ancestry.[29](#jvim15312-bib-0029){ref-type="ref"}, [30](#jvim15312-bib-0030){ref-type="ref"}

In conclusion, the genetic test for the *FAM134B* gene mutation is recommended when clinical signs are compatible with sensory neuropathy. Rare autosomal recessive genetic mutations previously identified in specific pure‐breed dogs should be considered as a differential diagnosis in mixed‐breed dogs with compatible clinical signs, especially if ancestry is unknown.
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